Table 3

 Change in polyp size (length × width) from baseline to final evaluation

PlaceboExisulind 200 mgExisulind 400 mg
*Comparison between exisulind 200 mg and placebo.
†Comparison between exisulind 400 mg and placebo.
Intent to treat population (n = 155)
    Total No544853
    Median (mm2)−2−4−4
    p Value (v placebo)0.7*0.3†
Efficacy evaluable population (n = 114)
    Total No433833
    Median (mm2)−4−4−10
    p Value (v placebo)0.9*0.03†